Fish or pills? study tests best way to boost young hearts

NCT ID NCT06729229

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study looks at whether eating two portions of fish per week or taking omega-3 supplements can improve blood vessel health and raise omega-3 levels in young adults aged 18 to 30. Participants with low omega-3 levels and little fish intake will be assigned to one of four groups: fish plus placebo, fish plus omega-3 supplement, omega-3 supplement alone, or placebo alone. The goal is to see if these simple changes can help prevent future heart disease.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
fish and omega-3 supplements
What this could lead to
If effective, this could show that simple dietary changes or supplements help young adults reach heart-healthy omega-3 levels, potentially reducing future cardiovascular risk.
What could go wrong
This is a small, early-stage study with 40 participants, so results may not apply to everyone. It tests short-term effects, not long-term disease prevention.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Nov 2024

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 30 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Omega 3 index \<6% Healthy males or females. * Aged 18-30 years old. * Low consumers of fish (\<2 portions/month). * Willing to 2 portions (280 grams) of fish per week. * Not consuming fish oil supplements. * Not consuming protein supplements. * Within a BMI of 18-30kg/m2 * Not allergic to seafood Exclusion Criteria: * Omega 3 index \>6% * Regularly consume fish. * Are allergic to seafood. * Are taking fish oil supplements (for example fish oil, cod oil, krill oil, GLA or evening primrose) or are taking protein supplements (for example whey protein). * Are pregnant/lactating. * Have existing health conditions such as Diabetes Mellitus and known hypertension. * Dietary restrictions resulting in the exclusion of fish such as vegan.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular prevention are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • NICHE, School of Biomedical Sciences, Biomedical Sciences Research Institute, Coleraine Campus, University of Ulster

    Coleraine, Co Londonderry, BT52 1SA, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.